Clinical Trial Update: Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating GW406381 for osteoarthritis of the knee has completed. The sponsor is GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• GW406381

Snippet

Sponsor: GlaxoSmithKline | Conditions: Osteoarthritis, Knee | Phase 3 | Status: COMPLETED